Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00146055 · ClinicalTrials.gov registry record · Phase 2
Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood
A Phase 2 study, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00146055 is a Phase 2 study that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 60 participants.
The verdict
NCT00146055, a Phase 2 study, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a less-intensive preparative therapy followed by an allogeneic peripheral stem cell transplantation will provide an effective treatment for your disease and whether it will be associated with fewer side effects.
Interventions
- PROCEDURE Reduced intensity conditioning with allogeneic transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2000-03 |
| Est. Completion | 2007-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00146055
The ClinicalTrials.gov registry entry for NCT00146055 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reduced intensity conditioning with allogeneic transplant is the first listed.
NCT00146055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00146055 about?
NCT00146055 is a clinical study titled "Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood". The purpose of this study is to determine whether a less-intensive preparative therapy followed by an allogeneic peripheral stem cell transplantation will provide an effective treatment for your disease and whether it will be associated with fewer side effects.
What is the current status of trial NCT00146055?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2000-03. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00146055?
The interventions under investigation include: Reduced intensity conditioning with allogeneic transplant (PROCEDURE).
Who is sponsoring clinical trial NCT00146055?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.